Darzalex IV
NDC 57894-505, Daratumumab, injection, solution, concentrate, from Janssen Biotech, Inc..
- Product NDC
- 57894-505
- Status
- Listed
- Labeler
- Janssen Biotech, Inc.
- Dosage form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761036
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/57894-505 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DARATUMUMAB100 mg/5mL
Pharmacologic classes
Antibodies, Monoclonal [CS]; CD38-directed Antibody Interactions [MoA]; CD38-directed Cytolytic Antibody [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 57894-505-05 | 57894050505 | 1 VIAL, SINGLE-DOSE in 1 BOX (57894-505-05) / 5 mL in 1 VIAL, SINGLE-DOSE |
| 57894-505-20 | 57894050520 | 1 VIAL, SINGLE-DOSE in 1 BOX (57894-505-20) / 20 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a4d0efe9-5e54-467e-9eb4-56fa7d53b60bMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=57894-505
Use it
Look up 57894-505 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/57894-505 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 57894-505. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.